复星医药：前三季度归母净利润同比增长25.50%

Core Viewpoint - Fosun Pharma reported a decline in revenue for the third quarter, while showing an increase in net profit year-on-year [1] Financial Performance - The company's revenue for the third quarter was 9.879 billion yuan, a year-on-year decrease of 5.46% [1] - The net profit attributable to shareholders for the third quarter was 821 million yuan, a year-on-year increase of 4.52% [1] - For the first three quarters, the total revenue was 29.393 billion yuan, a year-on-year decrease of 4.91% [1] - The net profit attributable to shareholders for the first three quarters was 2.523 billion yuan, a year-on-year increase of 25.50% [1]